Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Wyeth 1Q | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Wyeth 1Q

Revenues would have risen 2%, were it not for the impact of a strengthening dollar.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Wyeth 1Q

1Q Revenues: $5.4 billion (-6%)

1Q Earnings: $1.2 billion (flat)

Comments: Revenues would have risen 2%, were it not for the impact of a strengthening dollar. Enbrel sales (outside the U.S. and Canada) were $627 million (+3%). Prevnar sales were $755 million (+7%). Protonix sales were $215 million (+35%). Effexor sales were $819 million (-20%) and Zosyn sales $310 million (-9%), due to increased generic competition. Premarin sales were $246 million (-11)%.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters